Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LEVY, Jerrold H")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 109

  • Page / 5
Export

Selection :

  • and

Antifibrinolytic therapy: new data and new conceptsLEVY, Jerrold H.Lancet (British edition). 2010, Vol 376, Num 9734, pp 3-4, issn 0140-6736, 2 p.Article

Anaphylactic reactions in cardiac surgical patients: Et tu, brute?LEVY, Jerrold H.Journal of cardiothoracic and vascular anesthesia. 2001, Vol 15, Num 6, pp 677-679, issn 1053-0770Article

Novel intravenous antithrombinsLEVY, Jerrold H.The American heart journal. 2001, Vol 141, Num 6, pp 1043-1047, issn 0002-8703Article

Efficacy and safety of aprotinin in cardiac surgeryLEVY, Jerrold H.Orthopedics (Thorofare). 2004, Vol 27, Num 6, pp s659-s662, issn 0147-7447, SUPArticle

Inflammation, hemostasis, and blood conservation strategiesLEVY, Jerrold H.Hematology/oncology clinics of North America. 2007, Vol 21, Num 1, issn 0889-8588, 223 p.Conference Proceedings

Massive transfusion coagulopathyLEVY, Jerrold H.Seminars in hematology. 2006, Vol 43, Num 1, pp S59-S63, issn 0037-1963, SUP1Conference Paper

Biology of Factor XIII and clinical manifestations of Factor XIII deficiencyLEVY, Jerrold H; GREENBERG, Charles.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 5, pp 1120-1131, issn 0041-1132, 12 p.Article

Aprotinin: A pharmacologic overviewLEVY, Jerrold H; SYPNIEWSKI, Edward.Orthopedics (Thorofare). 2004, Vol 27, Num 6, pp s653-s658, issn 0147-7447, SUPArticle

Treatment of persistent tachycardia with dexmedetomidine during off-pump cardiac surgeryRUESCH, Sibylle; LEVY, Jerrold H.Anesthesia and analgesia. 2002, Vol 95, Num 2, pp 316-318, issn 0003-2999Article

A Case Series of Recombinant Platelet Factor 4 for Heparin Reversal After Cardiopulmonary BypassDEMMA, Linda; LEVY, Jerrold H.Anesthesia and analgesia. 2012, Vol 115, Num 6, pp 1273-1278, issn 0003-2999, 6 p.Article

Perioperative Hemostatic Management of Patients Treated with Vitamin K AntagonistsLEVY, Jerrold H; TANAKA, Kenichi A; DIETRICH, Wulf et al.Anesthesiology (Philadelphia). 2008, Vol 109, Num 5, pp 918-926, issn 0003-3022, 9 p.Article

Prohemostatic Agents to Prevent Perioperative Blood LossLEVY, Jerrold H; TANAKA, Kenichi A.Seminars in thrombosis and hemostasis. 2008, Vol 34, Num 5, pp 439-444, issn 0094-6176, 6 p.Article

The role of thrombin and protease-activated receptors in pain mechanismsGARCIA, Paul S; GULATI, Amitabh; LEVY, Jerrold H et al.Thrombosis and haemostasis. 2010, Vol 103, Num 6, issn 0340-6245, 1145-1151 [7 p.]Article

Managing the Patient Receiving Platelet Inhibitors in Cardiac Surgery: Roundtable DiscussionSMITH, Peter K; LEVY, Jerrold H.The Annals of thoracic surgery. 2000, Vol 70, Num 2, issn 0003-4975, 44 p., SUPConference Proceedings

Guidelines for Perioperative Blood Transfusion and Conservation in Cardiac Surgery: Lessons and ChallengesHESSEL, Eugene A; LEVY, Jerrold H.Anesthesia and analgesia. 2010, Vol 111, Num 6, pp 1555-1559, issn 0003-2999, 5 p.Article

Aprotinin and the systemic inflammatory response after cardiopulmonary bypassMOJCIK, Christopher F; LEVY, Jerrold H.The Annals of thoracic surgery. 2001, Vol 71, Num 2, pp 745-754, issn 0003-4975Article

Bleeding and management of coagulopathySNIECINSKI, Roman M; LEVY, Jerrold H.Journal of thoracic and cardiovascular surgery (Print). 2011, Vol 142, Num 3, pp 662-667, issn 0022-5223, 6 p.Article

Anaphylaxis During Cardiac Surgery : Implications for CliniciansLEVY, Jerrold H; FRANKLIN ADKINSON, N.Anesthesia and analgesia. 2008, Vol 106, Num 2, pp 392-403, issn 0003-2999, 12 p.Article

Inflammatory response to cardiopulmonary bypassLEVY, Jerrold H; TANAKA, Kenichi A.The Annals of thoracic surgery. 2003, Vol 75, Num 2, pp S715-S720, issn 0003-4975Conference Paper

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapyLEVY, Jerrold H; WELSBY, Ian; GOODNOUGH, Lawrence T et al.Transfusion (Philadelphia, PA). 2014, Vol 54, Num 5, pp 1389-1405, issn 0041-1132, 17 p.Article

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapyLEVY, Jerrold H; WELSBY, Ian; GOODNOUGH, Lawrence T et al.Transfusion (Philadelphia, PA). 2014, Vol 54, Num 5, issn 0041-1132, p. 1388Article

Prohemostatic Treatment in Cardiac SurgeryLEVY, Jerrold H; SNIECINSKI, Roman M.Seminars in thrombosis and hemostasis. 2012, Vol 38, Num 3, pp 237-243, issn 0094-6176, 7 p.Article

Hereditary Angioedema: Current and Emerging Treatment OptionsLEVY, Jerrold H; FREIBERGER, Douglas J; ROBACK, John et al.Anesthesia and analgesia. 2010, Vol 110, Num 5, pp 1271-1280, issn 0003-2999, 10 p.Article

The effect of aprotinin on activated protein C-mediated downregulation of endogenous thrombin generationTANAKA, Kenichi A; SZLAM, Fania; LEVY, Jerrold H et al.British journal of haematology. 2006, Vol 134, Num 1, pp 77-82, issn 0007-1048, 6 p.Article

Novel pharmacologic approaches to reduce bleedingLEVY, Jerrold H.Canadian journal of anaesthesia. 2003, Vol 50, Num 6, pp S26-S30, issn 0832-610X, SUPArticle

  • Page / 5